|
Bambusa vulgaris top
|
DB14321 |
[Bambusa vulgaris top is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.] |
|
Eucalyptus globulus leaf
|
DB14320 |
[Eucalyptus globulus leaf is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.] |
|
Grape seed oil
|
DB14323 |
[Grape seed oil is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.] |
|
Coconut oil
|
DB14322 |
[Coconut oil is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.] |
|
Bethanechol
|
DB01019 |
[Bethanechol is a synthetic ester structurally and pharmacologically related to acetylcholine. A slowly hydrolyzed muscarinic agonist with no nicotinic effects, bethanechol is generally used to increase smooth muscle tone, as in the GI tract following abdominal surgery or in urinary retention in the absence of obstruction. It may cause hypotension, cardiac rate changes, and bronchial spasms.] |
|
Guanfacine
|
DB01018 |
[A centrally acting antihypertensive agent. The drug lowers both systolic and diastolic blood pressure by activating the central nervous system alpha-2 adrenoreceptors, which results in reduced sympathetic outflow leading to reduced vascular tone. Its adverse reactions include dry mouth, sedation, and constipation.] |
|
Nicotinamide-adenine-dinucleotide-5-hydroxy-4-oxonorvaline
|
DB02349 |
|
|
(6,7-Difluoro-Quinazolin-4-Yl)-(1-Methyl-2,2-Diphenyl-Ethyl)-Amine
|
DB03678 |
|
|
2-Amino-3-(5-Tert-Butyl-3-(Phosphonomethoxy)-4-Isoxazolyl)Propionic Acid
|
DB02347 |
|
|
Sulfamethoxazole
|
DB01015 |
[A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)] |
|
Monofluorophosphate ion
|
DB02348 |
|
|
2-Hydroxy-Tryptophan
|
DB03679 |
|
|
Balsalazide
|
DB01014 |
[Balsalazide is an anti-inflammatory drug used in the treatment of Inflammatory Bowel Disease. It is sold under the name "Colazal" in the US and "Colazide" in the UK.
The chemical name is (E)-5-[[-4-(2-carboxyethyl) aminocarbonyl] phenyl]azo] -2-hydroxybenzoic acid. It is usually administered as the disodium salt.
Balsalazide works by deliverying mesalazine to the large intestine to act directly on ulcerative colitis. Mesalazine is also known as 5-aminosalicylic acid, or 5-ASA.] |
|
Minocycline
|
DB01017 |
[A tetracycline analog, having a 7-dimethylamino and lacking the 5 methyl and hydroxyl groups, which is effective against tetracycline-resistant staphylococcus infections.] |
|
Cystein-S-Yl Cacodylate
|
DB03676 |
|
|
Selenocysteine
|
DB02345 |
[A naturally occurring amino acid in both eukaryotic and prokaryotic organisms. It is found in tRNAs and in the catalytic site of some enzymes. The genes for glutathione peroxidase and formate dehydrogenase contain the TGA codon, which codes for this amino acid. [PubChem]] |
|
N-Cyclohexyl-N'-Decylurea
|
DB03677 |
|
|
3'-O-N-Octanoyl-a-D-Glucopyranosyl-B-D-Fructofuranoside
|
DB02346 |
|
|
Glyburide
|
DB01016 |
[Glyburide is a second generation sulfonylurea used to treat patients with diabetes mellitus type II.[L8123] It is typically given to patients who cannot be managed with the standard first line therapy, [metformin].[L8123] Glyburide stimulates insulin secretion through the closure of ATP-sensitive potassium channels on beta cells, raising intracellular potassium and calcium ion concentrations.[A183617]
Glyburide was granted FDA approval on 1 May 1984.[L8117] A formulation with metformin was granted FDA approval on on 31 July 2000.[L8120]] |
|
3,6,9,12,15-Pentaoxaheptadecane
|
DB02343 |
|
